Article
Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.
Antimicrobial agents and chemotherapy - 1 Aug 2001
Raimondi A, Sisto F, Nikaido H
Abstract excerpt
Starting from a clinical isolate of Serratia marcescens that produced a chromosomally encoded AmpC beta-lactamase inducibly, we isolated by stepwise selection two laboratory mutants that showed high levels of resistance to some cephalosporins. The 98R mutant apparently overproduced the unaltered beta-lactamase constitutively, but the 520R mutant produced an altered enzyme, also constitutively. Ceftazidime and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
